Clinical laboratory: Use and misuse, management models and health expenditure;El laboratorio clínico: Uso y abuso, modelos de gestión y gasto sanitario

Medicina Clinica

Volumn 125, Issue 16, 2005, Pages 622-625

  Rodríguez Espinosa, José ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CLINICAL LABORATORY; CLINICAL PRACTICE; CLINICAL RESEARCH; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MEDICAL TECHNOLOGY; REVIEW;

EID: 28944433045     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080838     Document Type: Article

References (42)

1. Conyers RAJ. Modifying use of pathology services [editorial]. Med J Aust. 1999;170:8-9.
2. Hammet RJH, Harris RD. Halting the growth in diagnostic testing. Med J Aust. 2002;177:124-5.
3. Larsson A, Palmer M, Hultén G, Tryding N. Large differences in laboratory utilisation between hospitals in Sweden. Clin Chem Lab Med. 2000;38:383-9.
4. Moore A. El gasto en el Sistema Nacional de Salud británico (NHS): el problema, sus dimensiones y como controlario [consultado 6/10/2004], Disponible en: www.infodoctor.org/bandolera/NHSfuturS.html
5. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA. 1998;280:550-8.
6. Stuart PJ, Crooks S, Porton M. An interventional program for diagnostic testing in the emergency department. Med J Aust. 2002;177:131-4.
7. Lundberg GD. Perseverance of laboratory test ordering: a syndrome affecting clinicians. JAMA. 1983;249:639.
8. Lundberg GD. The need for an outcomes research agenda for clinical laboratory testing. JAMA. 1998;280:565-6.
9. Cebul RD, Beck R. Biochemical profiles. Applications in ambulatory screening and preadmission testing of adults. Ann Intern Med. 1987;106:403-13.
10. Bates DW, Boyle D, Rittenberg E, Kuperman G, Luf NM, Menkin V, et al. What proportion of common diagnostic tests appear redundant? Am J Med. 1998;104:361-8.
11. Van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem. 2003;49:1997-2005.
12. Rodriguez Espinosa J, Queraltó Compañó JM. Sobre el uso clínico de los nuevos marcadores bioquímicos del metabolismo óseo. Med Clin (Barc). 1998;111:259-62.
13. Lundberg GD. The modern clinical laboratory: justification, scope, and directions. JAMA. 1975;232:528-9.
14. Schroeder SA, Schliftman A, Piemme TE. Variation among physicians in use of laboratory tests: relation to quality of care. Med Care. 1974;12:709-13.
15. Axt-Adam P, Van der Wouden C, Van der Does E. Influencing behaviour of physicians ordering laboratory tests: a literature study. Med Care. 1998;31:784-94.
16. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48:691-8.
17. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem. 2002;48:2008-16.
18. Ismail AAA, Walker PL, Barth JH, Lewandowski KC, Jones R, Burr W. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem. 2002;48:2023-9.
19. Sisson JC, Schoomaker EB, Ross JC. Clinical decision analysis. The hazard of using additional data. JAMA. 1976;236:1259-63.
20. Altshuler CH. Data utilization, not data acquisition, is the main problem. Clin Chem. 1994;40:1616-20.
21. Comisión de Hormonas de la Sociedad Española de Bioquímica Clínica y Patología Molecular. El laboratorio de hormonología y la automatización del inmunoanálisis. Endocrinología. 1995;42:233-5.
22. Fowkes FGR, Hall R, Jones JH, Scanlon MF, Elder GH, Hobbs DR, et al. Trial of strategy for reducing the use of laboratory tests. Br Med J. 1986;292:883-5.
23. Rodríguez Espinosa J, Montañés R, Ordóñez J, Cortés M, González F. Evaluación de una nueva estrategia para la detección de disfunción tiroidea. Med Clin (Barc). 1990;94:406-13.
24. Winkens RA, Pop P, Grol RO, Kester AD, Knottnerus JA. Effect of feedback on test ordering behaviour of general practitioners. BMJ. 1992;304:1093-6.
25. Black ER. Diagnostic strategies and test algorithms in liver disease. Clin Chem. 1997;43:1555-60.
26. Barth JH, Balen AH, Jennings A. Appropriate design of biochemistry request cards promote the use of protocols and reduce unnecessary investigations. Ann Clin Biochem. 2001;38:714-6.
27. Verstappen WH, Van der Weijden T, Sijbrandij J, Smeele I, Hermsen J, Grimshaw J, et al. Effect of a practice-based strategy on test ordering performance of primary care physicians. A randomised trial. JAMA. 2003;289:2407-12.
28. Neilson EG, Johnson KB, Rosenbloom ST, Dupont WD, Talbert D, Giuse DA, et al. The impact of peer management on test-ordering behavior. Ann Intern Med. 2004;141:196-204.
29. Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. JAMA. 1998;280:2020-7.
30. Winkens RA, Grol RP, Beusmans GH, Kester AD, Knottnerus JA, Pop P. Does a reduction in general practitioners' use of diagnostic tests lead to more hospital referrals? Br J Gen Pract. 1995;45:289-92.
31. Rodríguez Espinosa J, Comisión de Hormonas de la SEQC. Uso de las pruebas de función tiroidea en los laboratorios clínicos de la red sanitaria pública de Cataluña. Quim Clin. 2002;21:254-61.
32. Roti E, Gardini E, Magotti MG, Pilla S, Minelli R, Salvi M, et al. Are thyroid function tests too frequently and innappropriately requested? J Endocrinol Invest. 1999;22:184-90.
33. Ministerio de Sanidad y Consumo. Gasto público en Sanidad. Estadística del gasto sanitario. Serie enlazada 1960-2001 [consultado 6/10/2004]. Disponible en: http://www.msc.es/profesional/sistemaslnformacion/ analisisEconomico/estadGastoSanitario/documentos/serie_60_01Jmpren-ta.xls/
34. Kricka LJ. Interferences in immunoassay -still a threat [editorial]. Clin Chem. 2000;46:1037-8.
35. Waise A, Plebani M. Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? Ann Clin Biochem. 2001;38:589-95.
36. Bruns DE. Laboratory-related outcomes in healthcare. Clin Chem. 2001;47:1547-52.
37. Rodríguez Espinosa J. De privatizaciones y « analisazos». Med Clin (Bare). 1999;113:180-1.
38. Erickson K. Optimal use of the laboratory in the changing healthcare environment: do lab tests cost money or save money? Clin Chem. 1994;40:1615.
39. Young DS, Sachais BS, Jefferies LC. Laboratory costs in the context of disease. Clin Chem. 2000;46:967-75.
40. Ballesta Gimeno AM. Entrevista. Lab 2000. 1993; n.° 46 (septiembre):26-8.
41. Del Llano Señarís J, Millán Núñez- Cortés J. Ética y gestión sanitaria. Med Clin (Barc). 2002;118:337-8.
42. Kay JDS. Communicating with clinicians. Ann Clin Biochem. 2001;38:103-10.